Titolo |
Pubblicato in |
Anno |
Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
2024 |
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis |
ALLERGY |
2024 |
Treat-to-target in dermatology. a scoping review and international eczema council survey on the approach in atopic dermatitis |
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY |
2024 |
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies |
ALLERGY |
2024 |
Skin tape-strips in old order Mennonite toddlers reveal upregulated barrier markers and low T-helper inflammatory tone |
ALLERGY |
2024 |
Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY |
2024 |
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities |
ALLERGY |
2024 |
Proteomic alterations in patients with atopic dermatitis |
EXPERT REVIEW OF PROTEOMICS |
2024 |
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY |
2024 |
Diversity of atopic dermatitis and selection of immune targets |
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY |
2024 |
Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib |
MEDICINA |
2023 |
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study |
THE JOURNAL OF DERMATOLOGICAL TREATMENT |
2023 |
TFOS Lifestyle: Impact of cosmetics on the ocular surface |
THE OCULAR SURFACE |
2023 |
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI |
ARCHIVES OF DERMATOLOGICAL RESEARCH |
2023 |
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata |
ARCHIVES OF DERMATOLOGICAL RESEARCH |
2023 |
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata |
ALLERGY |
2023 |
Proteomic characterization of atopic dermatitis blood from infancy to adulthood |
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
2023 |
Cutaneous body image in psoriasis: The role of attachment style and alexithymia |
CURRENT PSYCHOLOGY |
2023 |
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin |
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
2023 |
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment among Patients with Eosinophilic Cellulitis |
JAMA DERMATOLOGY |
2023 |